Breast Cancer: Preop Targeted Tx Effective
SAN FRANCISCO (MedPage Today) -- Dual HER2-targeted neoadjuvant therapy led to odds of pathologic complete response similar to those associated with trastuzumab and chemotherapy, a meta-analysis suggested.
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Hematology | HER2 | Herceptin | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy